SCHEMBL695117

SCHEMBL695117

COc1ccc(S(=O)(=O)C2CC(C(=O)O)N(c3cc(C)nn3Cc3ccccc3)C2)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 1/20 0.46
CTSS P25774 8/20 0.42
CTSL P07711 5/20 0.40
CTSK P43235 2/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 1/20 0.39
KCNJ6 P48051 1/20 0.38
KCNJ5 P48544 1/20 0.38
KCNJ3 P48549 1/20 0.38
SLC16A3 O15427 2/20 0.37
SLC16A1 P53985 2/20 0.37
MCTS1 Q9ULC4 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL695116 1.00 AGTR2 (0.46) AGTR2CTSSCTSLCTSKALDH1A1
SCHEMBL696363 0.90 CTSS (0.49) AGTR2CTSSCTSLCTSKKCNJ6
SCHEMBL696364 0.90 CTSS (0.49) AGTR2CTSSCTSLCTSKKCNJ6
SCHEMBL697022 0.87 CTSS (0.57) CTSSCTSLCTSK
SCHEMBL696224 0.85 CTSS (0.47) AGTR2CTSSCTSLCTSKMAPT
SCHEMBL694624 0.84 CTSS (0.52) AGTR2CTSSCTSLCTSKKCNJ6
SCHEMBL694625 0.84 CTSS (0.52) AGTR2CTSSCTSLCTSKKCNJ6
SCHEMBL694626 0.84 CTSS (0.52) AGTR2CTSSCTSLCTSKKCNJ6
SCHEMBL695102 0.84 CTSS (0.44) AGTR2CTSSCTSLCTSKKCNJ6
SCHEMBL695103 0.84 CTSS (0.44) AGTR2CTSSCTSLCTSKKCNJ6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421826-A1 PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-02-29 EP disclosed
WO-2010121918-A1 PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-10-28 WO disclosed